Smith & Nephew Q3 Revenues Rise; Confirms FY18 View - Quick Facts

Shutterstock photo

Smith & Nephew Q3 Revenues Rise; Confirms FY18 View - Quick Facts

(RTTNews.com) - Medical technology business Smith & Nephew plc (SN.L, SNN) reported Thursday that its third-quarter revenue was $1.169 billion, up 2% on a reported basis and 3% on an underlying basis.

Underlying revenue growth was 4% in the US, and 10% in the Emerging Markets

In its third-quarter trading update, the company reported strong growth in Reconstruction, Sports Medicine Joint Repair and Advanced Wound Devices. Meanwhile, advanced Wound Bioactives continued to decline.

Further, the company confirmed full-year guidance.

Namal Nawana, Chief Executive Officer, said, "Improved underlying revenue growth in the third quarter was led by growth in the US and Emerging Markets. We are on-track to deliver our full year guidance. These results were achieved whilst successfully redesigning how we will run the company. There is still more to do, and I am pleased with the pace of progress and engagement across the organisation."

The company is moving to new global commercial structure to unlock value through specialist global franchises.

Read the original article on RTTNews (http://www.rttnews.com/2950117/smith-nephew-q3-revenues-rise-confirms-fy18-view-quick-facts.aspx)

For comments and feedback: contact editorial@rttnews.com

This article appears in: Fundamental Analysis , World Markets , Stocks , Economy , Earnings
Referenced Symbols: SNN

More from RTT News


See All RTT news

Research Brokers before you trade

Want to trade FX?